(Q35129615)

6 August 2017

title

Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures (English)

1 reference

6 August 2017

Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures (English)

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

3 January 2024

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

3 January 2024

author name string

Kian-Ti Yu

1

1 reference

6 August 2017

Sandra Mills

2

1 reference

6 August 2017

Nanora Thompson

3

1 reference

6 August 2017

Cedric Cunanan

4

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12752474

3 January 2024

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1528-1157.2003.41302.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752474

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1528-1157.2003.41302.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1528-1157.2003.41302.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

3 January 2024

1 reference

6 August 2017

volume

44

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

724-726

1 reference

Status epilepticus at an urban public hospital in the 1980s

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2003.41302.X

Rectal administration of sodium valproate in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2003.41302.X

Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2003.41302.X

Rectal valproate syrup and status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2003.41302.X

Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

Safety of intravenous valproate.

3 January 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients

3 January 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

Intravenous loading of valproate for epilepsy

3 January 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

The use of sodium valproate in a case of status epilepticus

3 January 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

Clinical experience of three pediatric and one adult case of spike-and-wave status epilepticus treated with injectable valproic acid

3 January 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

Intravenous valproate associated with significant hypotension in the treatment of status epilepticus

3 January 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.2003.41302.X

3 January 2024

Identifiers

1 reference

6 August 2017

1 reference